Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PARAGON Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer

NCT04119362 is registered in ClinicalTrials.gov with Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest as lead sponsor.

NCT NCT04119362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04119362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PARAGON Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer
Lead sponsor
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase
Observational
Overall status
Completed
Start date
October 24, 2019
Completion date
June 30, 2023
Enrollment
469 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic adenocarcinoma